PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹55 Cr | ₹33 Cr | ₹38 Cr | ₹136 Cr | ₹85 Cr |
What is the latest Total Non-Current Liabilities ratio of PFIZER ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹55 Cr |
Mar2024 | ₹33 Cr |
Mar2023 | ₹38 Cr |
Mar2022 | ₹136 Cr |
Mar2021 | ₹85 Cr |
How is Total Non-Current Liabilities of PFIZER Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹55 Cr | 67.65 | |
Mar2024 | ₹33 Cr | -14.76 | |
Mar2023 | ₹38 Cr | -71.81 | |
Mar2022 | ₹136 Cr | 60.16 | |
Mar2021 | ₹85 Cr | - |
Compare Total Non-Current Liabilities of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹24,338.9 Cr | 6.7% | -0.5% | -11.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | 6.7% |
-0.5% |
-11.5% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses